431 related articles for article (PubMed ID: 25337215)
21. Possible Concomitant Aggressive NK Cell Leukemia and EBV-positive T-cell lymphoma; Using the online beta version of WHO-HAEM5 and videoconferencing software to make diagnoses accessible in an emerging economy.
Dayton VJ; Hoang Thien D; Xinh PT; Arries C; Sang NN; Linh NNN; Lien NP; Dung PC
Diagn Pathol; 2023 Oct; 18(1):111. PubMed ID: 37803436
[TBL] [Abstract][Full Text] [Related]
22. Immunologic difference between hypersensitivity to mosquito bite and hemophagocytic lymphohistiocytosis associated with Epstein-Barr virus infection.
Lee WI; Lin JJ; Hsieh MY; Lin SJ; Jaing TH; Chen SH; Hung IJ; Yang CP; Chen CJ; Huang YC; Li SP; Huang JL
PLoS One; 2013; 8(10):e76711. PubMed ID: 24204658
[TBL] [Abstract][Full Text] [Related]
23. Clinicopathological characteristics of four cases of EBV positive T-cell lymphoproliferative disorders of childhood in China.
Huang W; Lv N; Ying J; Qiu T; Feng X
Int J Clin Exp Pathol; 2014; 7(8):4991-9. PubMed ID: 25197370
[TBL] [Abstract][Full Text] [Related]
24. A case of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis with severe cardiac complications.
Kawamura Y; Miura H; Matsumoto Y; Uchida H; Kudo K; Hata T; Ito Y; Kimura H; Yoshikawa T
BMC Pediatr; 2016 Oct; 16(1):172. PubMed ID: 27793118
[TBL] [Abstract][Full Text] [Related]
25. Hemophagocytic lymphohistiocytosis associated with Epstein-Barr virus in the central nervous system.
Magaki S; Ostrzega N; Ho E; Yim C; Wu P; Vinters HV
Hum Pathol; 2017 Jan; 59():108-112. PubMed ID: 27574808
[TBL] [Abstract][Full Text] [Related]
26. Differentiating fulminant EBV infection complicated by HLH from Lymphoma: report of a case and a brief literature review.
Zehr B; Brannock K; Wyma R; Kahwash SB
Diagn Pathol; 2023 Feb; 18(1):28. PubMed ID: 36814281
[TBL] [Abstract][Full Text] [Related]
27. Epstein-Barr virus-associated T- and NK-cell lymphoproliferative diseases: an update and diagnostic approach.
Hue SS; Oon ML; Wang S; Tan SY; Ng SB
Pathology; 2020 Jan; 52(1):111-127. PubMed ID: 31767131
[TBL] [Abstract][Full Text] [Related]
28. Immunophenotypic analysis of Epstein-Barr virus (EBV)-infected CD8(+) T cells in a patient with EBV-associated hemophagocytic lymphohistiocytosis.
Wada T; Kurokawa T; Toma T; Shibata F; Tone Y; Hashida Y; Kaya H; Yoshida T; Yachie A
Eur J Haematol; 2007 Jul; 79(1):72-5. PubMed ID: 17532761
[TBL] [Abstract][Full Text] [Related]
29. [Clinical and pathological features of 13 children with Epstein-Barr virus-positive lymphoproliferative disease].
Chen TM; Deng ZJ; Hu B; Hu HL; Chen HY; Li SY; Liu G
Zhonghua Er Ke Za Zhi; 2018 Oct; 56(10):759-764. PubMed ID: 30293280
[No Abstract] [Full Text] [Related]
30. Unraveling subcutaneous panniculitis-like T-cell lymphoma: An association between subcutaneous panniculitis-like T-cell lymphoma, autoimmune lymphoproliferative syndrome, and familial hemophagocytic lymphohistiocytosis.
LeBlanc RE; Lansigan F
J Cutan Pathol; 2021 Apr; 48(4):572-577. PubMed ID: 32894575
[TBL] [Abstract][Full Text] [Related]
31. Clinicopathological categorization of Epstein-Barr virus-positive T/NK-cell lymphoproliferative disease: an analysis of 42 cases with an emphasis on prognostic implications.
Paik JH; Choe JY; Kim H; Lee JO; Kang HJ; Shin HY; Lee DS; Heo DS; Kim CW; Cho KH; Kim TM; Jeon YK
Leuk Lymphoma; 2017 Jan; 58(1):53-63. PubMed ID: 27157296
[TBL] [Abstract][Full Text] [Related]
32. Pathogenesis and mechanism of disease progression from hemophagocytic lymphohistiocytosis to Epstein-Barr virus-associated T-cell lymphoma: nuclear factor-kappa B pathway as a potential therapeutic target.
Chuang HC; Lay JD; Hsieh WC; Su IJ
Cancer Sci; 2007 Sep; 98(9):1281-7. PubMed ID: 17627615
[TBL] [Abstract][Full Text] [Related]
33. Chronic active Epstein-Barr virus infection of T-cell type, systemic form in an African migrant: case report and review of the literature on diagnostics standards and therapeutic options.
Wass M; Bauer M; Pfannes R; Lorenz K; Odparlik A; Müller LP; Wickenhauser C
BMC Cancer; 2018 Oct; 18(1):941. PubMed ID: 30285657
[TBL] [Abstract][Full Text] [Related]
34. Flow cytometric findings in hemophagocytic lymphohistiocytosis.
McCall CM; Mudali S; Arceci RJ; Small D; Fuller S; Gocke CD; Vuica-Ross M; Burns KH; Borowitz MJ; Duffield AS
Am J Clin Pathol; 2012 May; 137(5):786-94. PubMed ID: 22523218
[TBL] [Abstract][Full Text] [Related]
35. Co-Occurrence of Familial Hemophagocytic Lymphohistiocytosis Type 2 and Chronic Active Epstein-Barr Virus in Adulthood.
Godby RC; Kraemer RR; May J; Soni S; Reddy V; Thomas JV; Mehta A
Am J Med Sci; 2021 Mar; 361(3):388-393. PubMed ID: 33309387
[TBL] [Abstract][Full Text] [Related]
36. [Clinical analysis and follow-up study of Epstein-Barr virus associated-hemophagocytic lymphohistiocytosis in childhood].
Lu G; Xie ZD; Shen KL; Wu RH; Jin YK; Yang S; Liu CY
Zhonghua Er Ke Za Zhi; 2010 Feb; 48(2):121-6. PubMed ID: 20426937
[TBL] [Abstract][Full Text] [Related]
37. Ileal mass-like lesion induced by Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in a patient with aplastic anemia.
Min KW; Jung HY; Han HS; Hwang TS; Kim SY; Kim WS; Lim SD; Kim WY
APMIS; 2015 Jan; 123(1):81-6. PubMed ID: 25243347
[TBL] [Abstract][Full Text] [Related]
38. Clinicopathological states of Epstein-Barr virus-associated T/NK-cell lymphoproliferative disorders (severe chronic active EBV infection) of children and young adults.
Suzuki K; Ohshima K; Karube K; Suzumiya J; Ohga S; Ishihara S; Tamura K; Kikuchi M
Int J Oncol; 2004 May; 24(5):1165-74. PubMed ID: 15067338
[TBL] [Abstract][Full Text] [Related]
39. Proposed categorization of pathological states of EBV-associated T/natural killer-cell lymphoproliferative disorder (LPD) in children and young adults: overlap with chronic active EBV infection and infantile fulminant EBV T-LPD.
Ohshima K; Kimura H; Yoshino T; Kim CW; Ko YH; Lee SS; Peh SC; Chan JK;
Pathol Int; 2008 Apr; 58(4):209-17. PubMed ID: 18324913
[TBL] [Abstract][Full Text] [Related]
40. Factors predicting the recurrence of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children after treatment using the HLH-2004 protocol.
Yanagaisawa R; Matsuda K; Ohga S; Kanegane H; Morimoto A; Okamoto Y; Ohara A; Fukushima K; Sotomatsu M; Nomura K; Saito AM; Horibe K; Ishii E; Nakazawa Y
Int J Hematol; 2019 May; 109(5):612-617. PubMed ID: 30788725
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
